Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alper Toker

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
The Annals of Thoracic Surgery|June 29, 2021
Superior Vena Cava Reconstruction in Masaoka Stage III and IVa Thymic Epithelial TumorsAlper Toker, J W Awori Hayanga, Ankit Dhamija, et al.
European Neurology|August 3, 2017
Prompt Response to Prednisone Predicts Benign Course in MuSK-MGOzlem Gungor-Tuncer, Vuslat Yilmaz, Alper Toker, et al.
Clinical Lung Cancer|July 7, 2011
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II studyAdnan Aydiner, Fatma Sen, Esra Kaytan Saglam, et al.
The Lancet. Respiratory Medicine|September 19, 2015
Invasive mediastinal staging is irrelevant for PET/CT positive N2 lung cancer if the primary tumour and ipsilateral lymph nodes are resectableEric Lim, Philip J McElnay, Gaetano Rocco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 20, 2024
Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify?Xun Luo, Jeremiah William Awori Hayanga, James Hunter Mehaffey, et al.
Oncology Research and Treatment|September 23, 2021
Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre ExperienceFerhat Ferhatoglu, Fahmin Amirov, Berker Ozkan, et al.
JTCVS Open|May 1, 2024
Mortality index is more accurate than volume in predicting outcome and failure to rescue in Medicare beneficiaries undergoing robotic right upper lobectomyJ W Awori Hayanga, Elwin Tham, Manuel Gomez-Tschrnko, et al.
The Annals of Thoracic Surgery|April 19, 2024
Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung SurgeryJ W Awori Hayanga, Xun Luo, Islam Hasasna, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2011
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancerFatma Sen, Esra Kaytan Saglam, Alper Toker, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2023
The relationship between body mass index and mortality is not linear in patients requiring venovenous extracorporeal supportElwin Tham, Stuart Campbell, Heather Hayanga, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
The Annals of Thoracic Surgery|June 29, 2021
Superior Vena Cava Reconstruction in Masaoka Stage III and IVa Thymic Epithelial TumorsAlper Toker, J W Awori Hayanga, Ankit Dhamija, et al.
European Neurology|August 3, 2017
Prompt Response to Prednisone Predicts Benign Course in MuSK-MGOzlem Gungor-Tuncer, Vuslat Yilmaz, Alper Toker, et al.
Clinical Lung Cancer|July 7, 2011
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II studyAdnan Aydiner, Fatma Sen, Esra Kaytan Saglam, et al.
The Lancet. Respiratory Medicine|September 19, 2015
Invasive mediastinal staging is irrelevant for PET/CT positive N2 lung cancer if the primary tumour and ipsilateral lymph nodes are resectableEric Lim, Philip J McElnay, Gaetano Rocco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 20, 2024
Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify?Xun Luo, Jeremiah William Awori Hayanga, James Hunter Mehaffey, et al.
Oncology Research and Treatment|September 23, 2021
Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre ExperienceFerhat Ferhatoglu, Fahmin Amirov, Berker Ozkan, et al.
JTCVS Open|May 1, 2024
Mortality index is more accurate than volume in predicting outcome and failure to rescue in Medicare beneficiaries undergoing robotic right upper lobectomyJ W Awori Hayanga, Elwin Tham, Manuel Gomez-Tschrnko, et al.
The Annals of Thoracic Surgery|April 19, 2024
Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung SurgeryJ W Awori Hayanga, Xun Luo, Islam Hasasna, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2011
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancerFatma Sen, Esra Kaytan Saglam, Alper Toker, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2023
The relationship between body mass index and mortality is not linear in patients requiring venovenous extracorporeal supportElwin Tham, Stuart Campbell, Heather Hayanga, et al.
Pageof 18